Physicians are using MRI to assess the association between sciatica symptoms and lumbar-disk herniation, despite controversy over its validity.
MRI is not a useful tool to determine the effectiveness of treatment for sciatica related to lumbar-disk herniation, according to a study published online in the New England Journal of Medicine.
Dutch researchers studied 283 patients who participated in a randomized trial comparing surgery for lumbar-disk herniation and sciatica with prolonged conservative treatment. The goal was to determine if the MRI could distinguish between patients with favorable and unfavorable outcomes.
The patients underwent MRI at baseline and again at one year. Disk herniation was rated on a scale of one to four, with one as “definitely present” and four as “definitely absent.” According to the authors, “A favorable clinical outcome was defined as complete or nearly complete disappearance of symptoms at one year.”
Upon comparing proportions of patients with favorable outcomes among those with definite absence of disk herniation, and those with definite, probable, or possible herniation, the researchers found that among the 84 percent of patients who reported having favorable outcomes, 35 percent had visible disk herniation. Thirty-three percent of patients with unfavorable outcomes also had disk herniations seen by MRI.
“A favorable outcome was reported in 85 percent of patients with disk herniation and 83 percent without disk herniation,” the authors wrote.
The researchers concluded that MRIs at one-year follow-up for lumbar-disk herniation did not distinguish between patients.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection
April 15th 2025Demonstrating no significant difference with radiologist detection of clinically significant prostate cancer (csPCa), a biparametric MRI-based AI model provided an 88.4 percent sensitivity rate in a recent study.
Could Ultrafast MRI Enhance Detection of Malignant Foci for Breast Cancer?
April 10th 2025In a new study involving over 120 women, nearly two-thirds of whom had a family history of breast cancer, ultrafast MRI findings revealed a 5 percent increase in malignancy risk for each second increase in the difference between lesion and background parenchymal enhancement (BPE) time to enhancement (TTE).